Depending on the intended use, and your desired results, the dosage levels are going to vary from person to person as well. So, keep this in mind when trying to determine how great the results are actually going to be when you are using Ipamorelin. So, what exactly can you expect when using this supplement? Some things you will see, for every user is:
Basic molecular pathophysiological cascade of acute myocardial infarction. Hypoxia triggers an acute failure in mitochondrial respiratory function when the diffusible oxygen stores become exhausted. Adenosine triphosphate reserves are rapidly depleted, and there is a respiratory shift toward an anaerobic profile. Lactate, H+ ions, CO2, and potassium accumulate may lead to arrhythmias, microendothelial damage, myocardiocytes stunning, and cell death. Adenosine triphosphate (ATP) depletion is irrevocably ligated to the inability of maintaining the normal negative resting membrane potential, to an alteration of calcium homeostasis (intracellular Ca2+ ([Ca2+]i) overload), which may eventually lead to different patterns of abnormal cardiac contraction. Mitochondrial functionality becomes abnormal, establishing the so-called “open pore” (mitochondrial permeability transition pore [mPTP]), leading to local cell death. In this scenario, mitochondria turn into an active ROS manufacturing plant that increases and perpetuates mitochondrial damages and dysfunction. The failure of myocardial contractility (contractility depression) is a precocious and multifactorial consequence of ischemia, which may eventually lead to reduced cardiac output and heart failure. This situation may translate into a self-perpetuated vicious circle, thus amplifying the ischemic episode and the myocardial wall stress. The local inflammatory reaction is a useful but critical operator within the myocardial ischemia/reperfusion damage process. Hypoxia itself activates the HIF-α/MIF axis and the consequent downstream inflammatory cascade. The locally secreted pro-inflammatory cytokines are involved in a self-perpetuating process in the ROS chain reaction, inflammation, and cellular damage.

There are some alternatives to GHPR-6 in the market which are easier to procure and considered legal in many countries. Natural supplements consisting of amino acids which are safer and non-hormonal when brought together may facilitate the increase of natural manufacturing of HGH. The effectiveness of these alternatives are likely to be inferior to the real deal but you should consider them if you are unlikely to get your hands on that precious prescription. Do a bit of research on your own and try finding the best option for you.
Growth hormone-releasing peptide 6 (GHRP-6) (developmental code name SKF-110679), also known as growth hormone-releasing hexapeptide, is one of several synthetic met-enkephalin analogues that include unnatural D-amino acids, were developed for their growth hormone-releasing activity and are called growth hormone secretagogues. They lack opioid activity but are potent stimulators of growth hormone (GH) release. These secretagogues are distinct from growth hormone releasing hormone (GHRH) in that they share no sequence relation and derive their function through activation of a completely different receptor. This receptor was originally called the growth hormone secretagogue receptor (GHSR), but due to subsequent discoveries, the hormone ghrelin is now considered the receptor's natural endogenous ligand, and it has been renamed as the ghrelin receptor. Therefore, these GHSR agonists act as synthetic ghrelin mimetics.